Use of natural killer cells in hematopoetic stem cell transplantation
- 17 January 2005
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 35 (7) , 637-643
Abstract
Adoptive immunotherapy using natural killer (NK) cells may prove useful, especially in situations where infusion of T cells is impractical such as in recipients of haploidentical stem cell transplantation (HSCT) from haploidentical donors. NK cells may induce potent antileukemic and possibly antirejection activity and may even mitigate graft versus host disease (GvHD). Whether such effects are clinically important and whether they are mediated mainly or exclusively by KIR–HLA class I interactions remains to be determined. Recent advances in graft engineering provide for methods to isolate large numbers of purified NK cells. Several groups have shown that clinical grade NK cells up to a dose of 107/kg may be collected and purified for the purpose of infusion to patients. Early results, in a limited number of patients, show that these cell doses may be administered without adverse events and without inducing GvHD. Whether such infusions will be useful in preventing graft rejection, or exerting graft versus leukemia effects and hastening immune recovery requires further study.Keywords
This publication has 47 references indexed in Scilit:
- Unravelling natural killer cell function: triggering and inhibitory human NK receptorsThe EMBO Journal, 2003
- The immunobiology of natural killer cells and bone marrow allograft rejectionTransplantation and Cellular Therapy, 2003
- Alloreactive killer cells: hindrance and help for haematopoietic transplantsNature Reviews Immunology, 2003
- New aspects of natural-killer-cell surveillance and therapy of cancerNature Reviews Cancer, 2002
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive ImmunityAnnual Review of Immunology, 2002
- What is a natural killer cell?Nature Immunology, 2002
- Allogeneic transplantation across major HLA barriersBest Practice & Research Clinical Haematology, 2001
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.Journal of Experimental Medicine, 1992